日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease

多功能化N-芳基磺酰基吲哚:(E)-N-羟基-3-{3-[(5-(3-(哌啶-1-基)丙氧基]-1H-吲哚-1-基)磺酰基]苯基}丙烯酰胺 (MTP150) 的鉴定及其在帕金森病表观遗传治疗中的应用

Toledano-Pinedo, Mireia; Porro-Pérez, Alicia; Schäker-Hübner, Linda; Diez-Iriepa, Daniel; Iriepa, Isabel; Siwek, Agata; Wolak, Małgorzata; Satała, Grzegorz; Bojarski, Andrzej J; Doroz-Płonka, Agata; Handzlik, Jadwiga; Godyń, Justyna; Dallemagne, Patrick; Rochais, Christophe; Davis, Audrey; Since, Marc; Pérez, Belén; Bellver-Sanchis, Aina; Irisarri, Alba; Pallàs, Mercè; Solana-Manrique, Cristina; López-Muñoz, Francisco; Ismaili, Lhassane; Griñán-Ferré, Christian; Paricio, Nuria; K Hansen, Finn; Więckowska, Anna; Marco-Contelles, José

Implication of Central β(2) Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease

中枢β(2)肾上腺素能受体在开发治疗阿尔茨海默病新药中的意义

Wang, Alice; Since, Marc; Dallemagne, Patrick; Rochais, Christophe

A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs

仿生多参数分析法鉴定抗淀粉样蛋白药物

Willy Smeralda, Marc Since, Sophie Corvaisier, Dimitri Fayolle, Julien Cardin, Sylvain Duprey, Jean-Pierre Jourdan, Christophe Cullin, Aurélie Malzert-Freon

Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment

用于治疗阿尔茨海默病的鼻腔给药复合纳米系统的药物技术开发

Thomas Adnet, Anne-Claire Groo, Céline Picard, Audrey Davis, Sophie Corvaisier, Marc Since, Frédéric Bounoure, Christophe Rochais, Loïc Le Pluart, Patrick Dallemagne, Aurélie Malzert-Fréon